MINI FUTURE LONG - INMODE Share Price

Certificat

DE000PC8Z927

Market Closed - Boerse Frankfurt Warrants 20:50:29 31/05/2024 BST
3.71 EUR +9.76% Intraday chart for MINI FUTURE LONG - INMODE
Current month+71.98%
1 month+71.98%
Date Price Change
31/05/24 3.56 +5.33%
30/05/24 3.38 -1.17%
29/05/24 3.42 -17.59%
28/05/24 4.15 +28.09%
27/05/24 3.24 +2.86%

Real-time Boerse Frankfurt Warrants

Last update May 31, 2024 at 08:50 pm

More quotes

Static data

Product typeKnock-Out mit Stop Loss
Buy / SellCALL
Underlying INMODE LTD.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC8Z92
ISINDE000PC8Z927
Date issued 29/04/2024
Strike 15.12 $
Maturity Unlimited
Parity 1 : 1
Emission price 2.21
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 4.17
Lowest since issue 1.68
Spread 0.02
Spread %0.53%

Company Profile

Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
Sector
-
More about the company

Ratings for InMode Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: InMode Ltd.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
19.13 USD
Average target price
25.6 USD
Spread / Average Target
+33.82%
Consensus